Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
Rhythm Pharmaceuticals has appointed Dr. Manher 'AJ' Joshi as Chief Medical Officer to accelerate the development and commercialization of its rare neuroendocrine disease therapies, including the FDA-approved setmelanotide. Dr. Joshi brings over 20 years of experience in clinical development and rare disease drug approval, supporting Rhythm's growt…